TR200000157T2 - Nitrik oksit rhinovirüsün bulaşmasını önler. - Google Patents
Nitrik oksit rhinovirüsün bulaşmasını önler.Info
- Publication number
- TR200000157T2 TR200000157T2 TR2000/00157T TR200000157T TR200000157T2 TR 200000157 T2 TR200000157 T2 TR 200000157T2 TR 2000/00157 T TR2000/00157 T TR 2000/00157T TR 200000157 T TR200000157 T TR 200000157T TR 200000157 T2 TR200000157 T2 TR 200000157T2
- Authority
- TR
- Turkey
- Prior art keywords
- nitric oxide
- rhinovirus
- transmission
- oxide prevents
- cytokinesis
- Prior art date
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title abstract 10
- 241000709661 Enterovirus Species 0.000 title 1
- 230000005540 biological transmission Effects 0.000 title 1
- 206010061494 Rhinovirus infection Diseases 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 230000021953 cytokinesis Effects 0.000 abstract 2
- 238000003786 synthesis reaction Methods 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 230000000770 proinflammatory effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 230000029812 viral genome replication Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Nitrik Oksit olusturan ya da Nitrik Oksit ile ilgili in situ sentezler meydana getiren bilesikler rinovirüs enfeksiyonlarinin inhibe edilmesinde kullanilabilir. Nitrik Oksit özellikle pro-enflamatuar sitokinez sirasinda, sitokinez sentezi de dahil olmak üzere viral replikasyonlari inhibe eden bir yetenege sahiptir. Buna ragmen, solunum yollarindaki nitrik oksidi arttirmak için yapilan tedavilerle rinovirüs enfeksiyonlari ile ilgili semptomlar iyilestirilebilir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5230797P | 1997-07-11 | 1997-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200000157T2 true TR200000157T2 (tr) | 2001-06-21 |
Family
ID=21976738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/00157T TR200000157T2 (tr) | 1997-07-11 | 1998-07-10 | Nitrik oksit rhinovirüsün bulaşmasını önler. |
Country Status (14)
Country | Link |
---|---|
US (1) | US6277891B1 (tr) |
EP (1) | EP1011657A1 (tr) |
JP (1) | JP2001509481A (tr) |
KR (1) | KR20010021749A (tr) |
CN (1) | CN1277552A (tr) |
AU (1) | AU8399098A (tr) |
BR (1) | BR9811473A (tr) |
CA (1) | CA2303430A1 (tr) |
CZ (1) | CZ200092A3 (tr) |
HU (1) | HUP0002859A2 (tr) |
ID (1) | ID23780A (tr) |
NO (1) | NO20000151L (tr) |
TR (1) | TR200000157T2 (tr) |
WO (1) | WO1999002148A1 (tr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR030753A1 (es) * | 2000-09-25 | 2003-09-03 | Smithkline Beecham Corp | Uso de moduladores-proteina de il-8, groalfa, grobeta, grogamma, nap-2, y ena-78, para tratar infecciones viricas |
GB0125222D0 (en) * | 2001-10-19 | 2001-12-12 | Barts & London Nhs Trust | Composition for the treatment of microbial infections |
DE10303196A1 (de) * | 2003-01-28 | 2004-08-12 | Märtz, Hans Helmut | Verwendung von Erzeugnissen, Stoffen oder Stoffgemischen, aus welchen im menschlichen oder tierischen Körper Stickoxid (Formel: NO) entsteht, zur Behandlung oder Prophylaxe von Infektionskrankheiten des menschlichen oder tierischen Körpers |
SE0300971D0 (sv) * | 2003-04-03 | 2003-04-03 | Aga Ab | Nitric oxide in treatment of inflammation |
CA2536827C (en) | 2003-07-09 | 2014-09-16 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Use of nitrite salts for the treatment of cardiovascular conditions |
US8252591B2 (en) * | 2004-05-07 | 2012-08-28 | Whitehead Institute For Biomedical Research | Hormone responsive tissue culture system and uses thereof |
US7362274B1 (en) * | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
WO2006125123A2 (en) | 2005-05-19 | 2006-11-23 | University Of Cincinnati | Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite |
GB0607402D0 (en) * | 2006-04-12 | 2006-05-24 | Barts & London Nhs Trust | Therapeutic composition and use |
EP2188367A4 (en) | 2007-08-10 | 2010-10-27 | Whitehead Biomedical Inst | HORMONE REACTIVE TISSUE CULTURE SYSTEM, AND USES THEREOF |
CA2710349A1 (en) * | 2007-12-27 | 2009-07-09 | Aires Pharmaceuticals, Inc. | Aerosolized nitrite and nitric oxide -donating compounds and uses thereof |
PL2276505T3 (pl) * | 2008-03-20 | 2014-01-31 | Karobio Ab | Sprej do nosa lub krople do nosa do leczenia przeziębienia |
WO2019005901A1 (en) * | 2017-06-27 | 2019-01-03 | Ohio State Innovation Foundation | NUCLEOTIDE THERAPY FOR ASTHMA |
CN109432122A (zh) * | 2018-11-19 | 2019-03-08 | 罗辉 | No或no供体在制备预防和/或治疗皮肤疾病或黏膜疾病药物中的应用及药物组合物 |
CN109846113A (zh) * | 2018-11-29 | 2019-06-07 | 南京诺全生物医疗科技有限公司 | 一种可自提供一氧化氮的口鼻卫生用品 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5455279A (en) | 1991-04-19 | 1995-10-03 | The Children's Medical Center Corporation | Regimen method of mediating neuronal damage using nitroglycerine |
-
1998
- 1998-07-10 BR BR9811473-5A patent/BR9811473A/pt not_active Application Discontinuation
- 1998-07-10 CZ CZ200092A patent/CZ200092A3/cs unknown
- 1998-07-10 AU AU83990/98A patent/AU8399098A/en not_active Abandoned
- 1998-07-10 WO PCT/US1998/014466 patent/WO1999002148A1/en not_active Application Discontinuation
- 1998-07-10 US US09/113,310 patent/US6277891B1/en not_active Expired - Fee Related
- 1998-07-10 CN CN98810536A patent/CN1277552A/zh active Pending
- 1998-07-10 JP JP2000501743A patent/JP2001509481A/ja active Pending
- 1998-07-10 HU HU0002859A patent/HUP0002859A2/hu unknown
- 1998-07-10 CA CA002303430A patent/CA2303430A1/en not_active Abandoned
- 1998-07-10 TR TR2000/00157T patent/TR200000157T2/tr unknown
- 1998-07-10 ID IDW20000272A patent/ID23780A/id unknown
- 1998-07-10 KR KR1020007000312A patent/KR20010021749A/ko not_active Application Discontinuation
- 1998-07-10 EP EP98934479A patent/EP1011657A1/en not_active Withdrawn
-
2000
- 2000-01-11 NO NO20000151A patent/NO20000151L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1011657A1 (en) | 2000-06-28 |
US6277891B1 (en) | 2001-08-21 |
CZ200092A3 (en) | 2001-05-16 |
AU8399098A (en) | 1999-02-08 |
CN1277552A (zh) | 2000-12-20 |
ID23780A (id) | 2000-05-11 |
BR9811473A (pt) | 2001-12-26 |
CA2303430A1 (en) | 1999-01-21 |
JP2001509481A (ja) | 2001-07-24 |
KR20010021749A (ko) | 2001-03-15 |
NO20000151L (no) | 2000-03-09 |
HUP0002859A2 (hu) | 2001-01-29 |
NO20000151D0 (no) | 2000-01-11 |
WO1999002148A1 (en) | 1999-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200000157T2 (tr) | Nitrik oksit rhinovirüsün bulaşmasını önler. | |
TR200003635T2 (tr) | Peg-IFN-ALFA ve ribavirinin kronik hepatit C tedavisinde kullanılması. | |
TR200102401T2 (tr) | C-21 Değiştirilmiş epotilonlar. | |
MY135721A (en) | Amidino compounds useful as nitric oxide synthase inhibitors | |
PT1315520E (pt) | Utilizacao de anticorpos trifuncionais biespecificos e triespecificos para tratamento de ascites malignas | |
EA200300628A1 (ru) | Соединения, специфические к аденозиновому a, aи aрецептору, и их применение | |
MY119031A (en) | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses | |
CY1107637T1 (el) | Θεραπευτικη αγωγη καρκινου προστατη με αντισωματα αντι - erbb2 | |
TR200000928T2 (tr) | Yeni kombinasyon. | |
TR200101895T2 (tr) | Cinsel rahatsızlıkların tedavisi. | |
BR8807886A (pt) | Corpo em forma de colmeia, sobretudo com camadas de placas metalicas parcialmente reforcadas em forma de s. | |
ATE363896T1 (de) | Gegen missbrauch gesicherte darreichungsform | |
SE9701162D0 (sv) | New use II | |
TR200102773T2 (tr) | Alkoksisilan yapısal birimleri olan poliüretan eriyikleri | |
ES2191292T3 (es) | Compuestos antivirales poliaromaticos. | |
TR199802769T2 (tr) | Terpenoid bilesikler ile antihistaminik bilesiklerin bir kombinasyonunu ihtiva eden topikal bilesim. | |
TR200001040T2 (tr) | Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı | |
TR200100455T2 (tr) | Nimesulid içeren topikal farmasötik bileşimler | |
GB9708092D0 (en) | Materials and methods relating to inhibiting the interaction of p53 and mdm2 | |
DE69117303D1 (de) | Zusammensetzung mit psyllium | |
TR200200246T2 (tr) | Nezle ve grip benzeri hastalıklar ile ilişkilendirilen semptomlardan korunma ve bunların tedavisi ile ilgili bileşim. | |
DE69905468D1 (de) | Sporizide zusammensetzung | |
TR200102944T2 (tr) | İntegrin reseptör ligandları | |
MXPA02012911A (es) | Compuestos de rutenio (ii) para el uso en terapia del cancer. | |
BR0011261A (pt) | Composição oral compreendendo perlita, e, uso de perlita |